about
Three Metachronous Cases of HER2-Positive Breast Cancer Accompanied with Thyroid Cancer.The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.Molecular biology of head and neck cancer: risks and pathways.DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner.Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.Collision metastasis of breast and thyroid carcinoma to a single cervical lymph node: report of a case.
P2860
Q35066950-13E970CC-4DFB-40AB-9906-E8E48EBD9D59Q35091427-813B2C05-332F-4544-829D-C931FF19BC80Q37325829-36755984-F805-4A0B-ACA9-612BD9648515Q39890321-3124477F-9C28-47E0-B057-3FC0FD3DDE98Q41995223-8B4164E8-0768-455E-BDCB-A2D549CF3951Q44273702-6A79D78D-3013-4D1C-9045-599EEA920419Q51347872-6E2EB2A0-7EDF-480F-B612-5BCEE0D5B522
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Akt: a potential target for thyroid cancer therapy.
@ast
Akt: a potential target for thyroid cancer therapy.
@en
type
label
Akt: a potential target for thyroid cancer therapy.
@ast
Akt: a potential target for thyroid cancer therapy.
@en
prefLabel
Akt: a potential target for thyroid cancer therapy.
@ast
Akt: a potential target for thyroid cancer therapy.
@en
P2093
P356
P1476
Akt: a potential target for thyroid cancer therapy.
@en
P2093
Faiza Kada
Matthew D Ringel
Motoyasu Saji
P304
P356
10.2174/1568008043339857
P577
2004-09-01T00:00:00Z